Recognition of local anesthetics by αβ+ T cells

Journal of Investigative Dermatology

Volumn 112, Issue 2, 1999, Pages 197-204

  Zanni, Martin P ^a   Von Greyerz, Salome ^a   Hari, Yvonne ^a   Schnyder, Benno ^a   Pichler, Werner J ^a,b  

^a Inselspital   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cross reactivity; Drug allergy; Nonpeptide antigens; T cell clones

Indexed keywords

BUPIVACAINE; BUTANILICAINE; ETIDOCAINE; LIDOCAINE; MEPIVACAINE; OXYBUPROCAINE; PRILOCAINE; TETRACAINE; TOCAINIDE;

ANTIGEN RECOGNITION; ARTICLE; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; HUMAN; IMMUNOPATHOGENESIS; LOCAL ANESTHESIA; PATCH TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032891828     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00484.x     Document Type: Article

References (29)

1. Akil H, Mayer DM, Liebeskind JC: Antagonism of stimulation-produced analgesia by naloxone. Science 191:961-962, 1976
2. Bircher A, Langauer JS, Surber C, Rufli T: Delayed type hypersensitivity to subcutaneous lidocaine with tolerance of articaine. Confirmation by in vivo and in vitro tests. Contact Dermatitis 34:387-389, 1996
3. Blanca M, Fernandez J, Miranda A, et al: Cross-reactivity between penicillins and cephalosporins: Clinical and immunogenic studies. J Allergy Clin Immunol 83:381-385, 1989
4. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ: Heterogeneous T cell responses to β-lactam-modified self structures are observed in penicillin allergic individuals. J Immunol 155:2670-2678, 1995
5. Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP: Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metabol Dispos 19:900-906, 1991
6. Curley R, Macfarlane K, King CM: Contact sensitivity to the amide anesthetics lidocaine, prilocaine and mepivacaine. Arch Dermatol 122:924-926, 1986
7. Evavold BD, Allen PM: Seperation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308-1310, 1991
8. van de Hove J, Decroix J, Tennstedt D, Lachapelle JM: Allergic contact dermatitis from prilocaine, one of the local anesthetics in EMLA cream. Contact Dermatitis 30:239, 1994
9. + T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine. J Immunol 155:462-472, 1995
10. Mauri-Hellweg D, Zanni MP, Frei E, Bettens F, Brander C, Pichler WJ: Crossreactivity of T cell lines and clones to β-lactam antibiotics. J Immunol 157:1071-1079, 1996
11. Miranda A, Blanca M, Vega JM, et al: Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 98:671-677, 1996
12. Mohler H, Richards JG: Agonist and antagonist benzodiazepine receptor interaction in vivo. Nature 294:763-765, 1981
13. Nyfeler B, Pichler WJ: The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27:175-181, 1997
14. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU: T cell recognition of penicillinG: structural features determining antigenic specificity. Eur J Immunol 26:42-48, 1996
15. Padovan E, Bauer T, Tongio MM, Karlbacher H, Weltzien HU: Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 27:1303-1307, 1997
16. Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S: Role of T-cells in drug allergies. Allergy 53:225-232, 1998
17. Preckel T, Grimm R, Martin S, Weltzien HU: Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J Exp Med 185:1803-1813, 1997
18. Rao A, Faas SJ, Cantor H: Analogs that compete for antigen binding to an arsonate-reactive T-cell response to arsonate. Cell 36:889-895, 1984
19. Rao A, Weng-Ping Ko W, Faas S, Cantor H: Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones. Cell 36:879-888, 1994
20. Rhodes J, Chen H, Hall SH, Beesley JE, Jenkins DC, Collins P, Zheng B: Therapeutic potentiation of the immune system by costimulatory schiff-base-forming drugs. Nature 376:16-17, 1995
21. Rieder MJ, Uetrecht J, Shear NH, Cannon M, Miller M, Spielberg SP: Diagnosis of sulfonamide hypersensitivity reactions by in-vitro rechallenge, with hydroxylamine metabolites. Ann Intern Med 110:286-289, 1989
22. Romagnoli P, Labhardt AM, Sinigaglia F: Selective interaction of Ni with an MHC-bound peptide. EMBO J 10:1303-1307, 1991
23. Schnyder B, Mauri-Hellweg D, Zanni MP, Bettens F, Pichler WJ: Direct, MHC dependent presentation of the drug sulfamethoxazole to αβ+ T cell clones. J Clin Invest 100:136-141, 1997
24. Silviu-Dan F, McPhillips S, Warrington RJ: The frequency of skin test reactions to side-chain penicillin determinants. J Allergy Clin Immunol 91:694-701, 1992
25. Sloan-Lancaster J, Evavold BD, Allen PM: Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156-159, 1993
26. Sloan-Lancaster J, Steinberg TH, Allen PM: Selective activation of the calcium signaling pathway by altered peptide ligands. J Exp Med 184:1525-1530, 1996
27. Zanni MP, Mauri-Hellweg D, Brander C, et al: Characterization of lidocaine specific T cells. J Immunol 158:1139-1148, 1997
28. Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ: Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Int Immunol 10:507-515, 1998a
29. Zanni MP, Schnyder B, von Greyerz S, Pichler WJ: Recognition of drugs by specific T cells. Trends Pharm Sci 8:308-310, 1998b